| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,404 |
10,907 |
$2.84M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,526 |
3,483 |
$2.49M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,359 |
5,668 |
$1.57M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,811 |
7,418 |
$963K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,764 |
2,986 |
$681K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,946 |
1,742 |
$663K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,879 |
1,700 |
$577K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,348 |
3,681 |
$533K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,694 |
1,128 |
$486K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,610 |
2,105 |
$294K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
986 |
782 |
$271K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,482 |
1,926 |
$210K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,017 |
1,703 |
$206K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,146 |
818 |
$202K |
| G0378 |
Hospital observation service, per hour |
2,566 |
1,097 |
$107K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
342 |
186 |
$97K |
| 97597 |
|
611 |
214 |
$73K |
| 80053 |
Comprehensive metabolic panel |
8,550 |
6,363 |
$63K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
181 |
165 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,471 |
6,797 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
888 |
633 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
969 |
879 |
$33K |
| 87631 |
|
302 |
277 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
333 |
275 |
$29K |
| 84145 |
|
2,603 |
1,930 |
$28K |
| 90834 |
Psychotherapy, 45 minutes with patient |
561 |
321 |
$24K |
| 80320 |
|
1,132 |
855 |
$22K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
108 |
102 |
$21K |
| 84484 |
|
3,409 |
2,177 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
608 |
420 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
1,977 |
1,347 |
$17K |
| 81001 |
|
6,522 |
5,199 |
$17K |
| 80306 |
|
1,414 |
1,095 |
$17K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
43 |
26 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
285 |
239 |
$13K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,927 |
2,178 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,667 |
2,551 |
$12K |
| 83605 |
|
2,742 |
1,902 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,661 |
1,780 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
42 |
26 |
$11K |
| 87040 |
|
2,766 |
1,268 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,418 |
568 |
$10K |
| 83690 |
|
2,124 |
1,685 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
917 |
740 |
$9K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
23 |
12 |
$8K |
| 81025 |
|
926 |
776 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
98 |
62 |
$7K |
| 85027 |
|
2,547 |
1,802 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,507 |
2,773 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
218 |
182 |
$7K |
| 0003U |
Infec agen detec ampli probe |
58 |
47 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
105 |
90 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,170 |
1,003 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
4,654 |
2,595 |
$5K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
110 |
93 |
$5K |
| 86140 |
|
1,430 |
1,137 |
$4K |
| 82962 |
|
2,593 |
1,057 |
$4K |
| 85007 |
|
2,292 |
1,647 |
$4K |
| 87186 |
|
801 |
672 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,622 |
3,324 |
$3K |
| 0100U |
|
54 |
50 |
$3K |
| 84703 |
|
488 |
406 |
$3K |
| 80051 |
|
488 |
449 |
$3K |
| 85610 |
|
1,383 |
960 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63 |
55 |
$3K |
| 82565 |
|
835 |
723 |
$3K |
| 85378 |
|
516 |
412 |
$2K |
| 83735 |
|
768 |
503 |
$2K |
| 94760 |
|
5,184 |
4,203 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
22 |
13 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
106 |
95 |
$2K |
| 83880 |
|
193 |
164 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
44 |
32 |
$2K |
| 99201 |
|
13 |
13 |
$2K |
| 84520 |
|
542 |
495 |
$1K |
| 87081 |
|
96 |
89 |
$1K |
| 84460 |
|
372 |
333 |
$1K |
| 97162 |
|
52 |
38 |
$1K |
| 84450 |
|
327 |
301 |
$1K |
| 73610 |
|
61 |
39 |
$962.13 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,178 |
2,329 |
$958.38 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
42 |
13 |
$864.84 |
| 36415 |
Collection of venous blood by venipuncture |
6,369 |
4,191 |
$800.90 |
| 80143 |
|
67 |
52 |
$687.05 |
| 80179 |
|
66 |
52 |
$649.18 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18 |
13 |
$601.24 |
| 82247 |
|
161 |
115 |
$470.13 |
| 86618 |
|
38 |
33 |
$416.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,611 |
2,570 |
$406.12 |
| 87641 |
|
91 |
66 |
$309.56 |
| 51702 |
|
15 |
12 |
$303.24 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
178 |
74 |
$265.15 |
| 73030 |
|
28 |
13 |
$234.82 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,632 |
2,601 |
$192.21 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,399 |
1,667 |
$184.29 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
108 |
104 |
$182.50 |
| 87205 |
|
60 |
53 |
$182.14 |
| J3490 |
Unclassified drugs |
6,511 |
2,666 |
$179.90 |
| 87070 |
|
28 |
26 |
$176.09 |
| 80061 |
Lipid panel |
12 |
12 |
$124.56 |
| 96376 |
|
621 |
396 |
$103.91 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
49 |
$95.89 |
| 84075 |
|
28 |
28 |
$93.32 |
| 87077 |
|
24 |
14 |
$83.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,969 |
1,625 |
$79.05 |
| 82947 |
|
41 |
37 |
$75.66 |
| J2704 |
Injection, propofol, 10 mg |
1,098 |
888 |
$72.63 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,001 |
2,255 |
$59.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
925 |
713 |
$49.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,666 |
1,294 |
$45.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
418 |
263 |
$44.27 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,198 |
1,021 |
$39.24 |
| 99219 |
|
55 |
52 |
$25.52 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,926 |
1,058 |
$17.28 |
| J2060 |
Injection, lorazepam, 2 mg |
34 |
25 |
$1.83 |
| 99156 |
|
25 |
24 |
$0.55 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
75 |
55 |
$0.36 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
47 |
36 |
$0.09 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
28 |
26 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
82 |
51 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
242 |
201 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
148 |
117 |
$0.00 |
| A9270 |
Non-covered item or service |
1,123 |
193 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
237 |
197 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
73 |
53 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
21 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
12 |
$0.00 |
| 99217 |
|
26 |
24 |
$0.00 |
| 94761 |
|
20 |
12 |
$0.00 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
18 |
16 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
70 |
48 |
$0.00 |
| 73630 |
|
16 |
12 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
12 |
12 |
$0.00 |